Clinical Trials on Primary Sjögren Syndrome in New Zealand

Total 10599 results

University of Rochester

Completed

Pilot Trial of Ustekinumab for Primary Sjögren's Syndrome

Primary Sjögren Syndrome

United States
PAVmed Inc.

Completed

PAVmed CarpX Device Clinical Study

Carpal Tunnel Syndrome

New Zealand
University of Auckland, New Zealand
Auckland Medical Research Foundation; Mercia Barnes Trust of the Royal Australian...

Completed

PCOSMIC Trial - PolyCystic Ovary Syndrome, Metformin for Infertility With Clomiphene (PCOSMIC)

Polycystic Ovary Syndrome

New Zealand
Fisher and Paykel Healthcare

Terminated

Toffee Full Face and Toffee Nasal Mask Evaluation in Obesity Hypoventilation Syndrome (NZ)

Obesity Hypoventilation Syndrome

New Zealand
Aldeyra Therapeutics, Inc.

Completed

RESET Trial - Part 1 - A Phase 3 Trial in Subjects With Sjögren-Larsson Syndrome (SLS)

Sjogren-Larsson Syndrome

United States
Fisher and Paykel Healthcare

Terminated

Feasibility of a Modified Positive Airway Pressure Device to Treat Sleep Disordered Breathing

Sleep Apnea, Obstructive | Obesity Hypoventilation Syndrome

New Zealand
Zealand University Hospital
University of Copenhagen; Pharma Nord; Psychiatric Research Unit, Region Zealand...

Completed

The Effect of MElatonin on Depression, Anxiety, CIrcadian and Sleep Disturbances in Patients After Acute Myocardial Syndrome (MEDACIS)

Depression | Acute Coronary Syndrome

Denmark
National Institute of Allergy and Infectious Diseases...
Biogen; Autoimmunity Centers of Excellence

Terminated

Baminercept, a Lymphotoxin-Beta Receptor Fusion Protein, for Treatment of Sjögren's Syndrome

Primary Sjögren's Syndrome

United States
Novartis Pharmaceuticals

Completed

Safety, Pharmacokinetics and Preliminary Efficacy Study of CFZ533 in Patients With Primary Sjögren's Syndrome

Primary Sjögren's Syndrome

United States, Hungary, Germany, Switzerland, United Kingdom
Novartis Pharmaceuticals

Completed

Safety and Efficacy of VAY736 in Patients With Primary Sjogren's Syndrome (pSS)

Primary Sjogren Syndrome

United States, Belgium, Italy, Austria, Israel, France, Germany, Hungary, Netherlands, United Kingdom, Japan, Portugal, Argentina, Spain, Taiwan, Russian Federation, Romania, Chile, Poland
TearSolutions, Inc.

Completed

Lacripep™ in Subjects With Dry Eye Associated With Primary Sjögren's Syndrome

Dry Eye | Primary Sjögren Syndrome

United States
Zhejiang Doer Biologics Co., Ltd.

Recruiting

A First in Human (FIH) Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of DR10624

Healthy, Obesity, Metabolically

New Zealand
Fisher and Paykel Healthcare

Completed

Novel Auto-continuous Positive Airway Pressure (CPAP) Validation

Sleep Apnea, Obstructive

New Zealand
National University Heart Centre, Singapore
AstraZeneca

Recruiting

PASSIvation of Vulnerable Plaque With AZD5718 in AcuTe Coronary syndromE (PASSIVATE)

Acute Coronary Syndrome

Australia, New Zealand, Singapore
Fisher and Paykel Healthcare

Completed

Investigative Headgear With CPAP Mask

Obstructive Sleep Apnea

New Zealand
Fisher and Paykel Healthcare

Completed

Investigative Headgear With Nasal Pillows Continuous Positive Airway Pressure (CPAP) Mask

Obstructive Sleep Apnea

New Zealand
Fisher and Paykel Healthcare

Completed

CPAP In-home Assessment NZ

Obstructive Sleep Apnea

New Zealand
Fisher and Paykel Healthcare

Completed

Comparison of Breathing Events Detected by the SleepStyle 200 Auto Continuous Positive Airway Pressure (CPAP) Device to Attended Polysomnography

Sleep Apnea, Obstructive

New Zealand
Fisher and Paykel Healthcare

Completed

CPAP Device In-lab Assessment NZ

Obstructive Sleep Apnea

New Zealand
Novartis Pharmaceuticals

Completed

Study of Safety and Efficacy of Multiple Doses of CFZ533 in Two Distinct Populations of Patients With Sjogren's Syndrome (TWINSS)

Sjögren Syndrome

United States, United Kingdom, Netherlands, Australia, Austria, Israel, France, Germany, Greece, Hungary, Italy, Korea, Republic of, Japan, Portugal, Russian Federation, Turkey, Canada, Colombia, Romania, Argentina, Chile, Brazil, S...
Fisher and Paykel Healthcare

Completed

Validation of HC250 and HC240 Series.

Obstructive Sleep Apnea (OSA)

New Zealand
Fisher and Paykel Healthcare

Completed

An Investigation to Test a Prototype Nasal Mask in the Home Setting

Obstructive Sleep Apnea | Sleep Disordered Breathing

New Zealand
Fisher and Paykel Healthcare

Terminated

Physiological Study to Compare Noninvasive Ventilation (NIV) Masks

Sleep-disordered Breathing | Hypercapnia

New Zealand
Fisher and Paykel Healthcare

Completed

The Evaluation of a Novel Nasal Pillows Mask for the Treatment of Obstructive Sleep Apnea

Obstructive Sleep Apnea

New Zealand
CSL Limited

Completed

Safety Study of Subcutaneous Ig NextGen 16% in Patients With Primary Immunodeficiency

Primary Immune Deficiency

Australia, New Zealand
Fisher and Paykel Healthcare

Completed

The Evaluation of a Nasal Mask for the Treatment of Obstructive Sleep Apnea (OSA): Comfort & Performance Trial

Obstructive Sleep Apnea | Sleep Disordered Breathing

New Zealand
Fisher and Paykel Healthcare

Completed

The Evaluation of a Nasal Mask for the Treatment of Obstructive Sleep Apnea

Obstructive Sleep Apnea | Sleep Disordered Breathing

New Zealand
Fisher and Paykel Healthcare

Completed

The Evaluation of a Mask Seal/Mask for the Treatment of Obstructive Sleep Apnea (OSA)

Obstructive Sleep Apnea | Sleep Disordered Breathing

New Zealand
Fisher and Paykel Healthcare

Completed

The Evaluation of a Nasal Mask for the Treatment of Obstructive Sleep Apnea (OSA)

Obstructive Sleep Apnea | Sleep Disordered Breathing

New Zealand
Fisher and Paykel Healthcare

Completed

Evaluation of Treatment Efficacy and Comfort of a Modified Positive Airway Pressure Device to Treat Obstructive Sleep Apnea.

Obstructive Sleep Apnea (OSA)

New Zealand
University of Auckland, New Zealand

Unknown

The In Vitro Fertilization - Lipiodol Uterine Bathing Effect Study

Endometriosis | In Vitro Fertilization Implantation Failure

New Zealand
GlaxoSmithKline

Completed

Single Dose Safety Study for Compound to Treat Anemia in Patients With Renal Impairment

Kidney Disease

New Zealand
Amgen

Recruiting

A Safety and Efficacy Study of Dazodalibep in Participants With Sjögren's Syndrome (SS) With Moderate-to-Severe Symptom State

Sjögren's Syndrome (SS)

United States
Fisher and Paykel Healthcare

Completed

Evaluation of a Nasal Mask for the Treatment of Obstructive Sleep Apnea in New Zealand

Obstructive Sleep Apnea

New Zealand
Fisher and Paykel Healthcare

Terminated

Evaluation of Treatment Efficacy of a Modified Positive Airway Pressure Device to Treat Obstructive Sleep Apnea

Obstructive Sleep Apnea

New Zealand
Fisher and Paykel Healthcare

Completed

An Investigation to Test a Prototype Full-face Mask in the Home Setting

Obstructive Sleep Apnea | Sleep Disordered Breathing

New Zealand
Fisher and Paykel Healthcare

Completed

The Evaluation of a Novel Nasal Mask for the Treatment of Obstructive Sleep Apnea

Obstructive Sleep Apnea

New Zealand
The Fertility Centre, New Zealand

Completed

Local Anaesthetic for Transvaginal Egg Collection in IVF

Infertility

New Zealand
Fisher and Paykel Healthcare

Completed

The Evaluation of a Nasal Pillows Mask for the Treatment of Obstructive Sleep Apnea (OSA)

Obstructive Sleep Apnea | Sleep Disordered Breathing

New Zealand
Hoffmann-La Roche

Completed

A Multiple-Dose Study of Oral Oseltamivir in Participants on Hemodialysis (HD) and Continuous Ambulatory Peritoneal Dialysis (CAPD)

End Stage Renal Disease

New Zealand
Bristol-Myers Squibb

Terminated

Proof of Concept Study to Evaluate the Efficacy and Safety of BMS-931699 (Lulizumab) or BMS-986142 in Primary Sjögren's Syndrome

Sjögren's Syndrome

Australia, United States, Italy, Mexico, Colombia, Peru, Puerto Rico, South Africa, Chile, Poland, Russian Federation
Eli Lilly and Company

Completed

A Study of LY3090106 in Participants With Sjögren's Syndrome (SS)

Sjögren's Syndrome

United States, Bulgaria, Georgia, Romania
The Medicines Company

Completed

A Study of Inclisiran in Participants With Renal Impairment Compared to Participants With Normal Renal Function (ORION-7)

Renal Impairment

New Zealand
Fisher and Paykel Healthcare

Terminated

Humidification Needs

Obstructive Sleep Apnea

New Zealand
Academy of Nutrition and Dietetics

Completed

Can Dietitians Reduce Interdialytic Weight Gain in at Risk Hemodialysis Patients Through Tailored Education on Dietary Sodium and Fluid Intake?

End Stage Renal Disease Requiring Hemodialysis

New Zealand
Novartis Pharmaceuticals

Recruiting

Three-arm Study to Assess Efficacy and Safety of Ianalumab (VAY736) in Patients With Active Sjogren's Syndrome (NEPTUNUS-2)

Sjogren Syndrome

United States, Lebanon, India, Spain, Hungary, Germany, Brazil, Israel, Canada, China, Italy, Chile, Colombia, Argentina, Greece, United Kingdom, Australia, Bulgaria, Japan, Mexico, South Africa, Taiwan, France, Romania, Poland, Slovakia, S...
Arrowhead Pharmaceuticals

Recruiting

Study of ARO-CFB in Adult Healthy Volunteers and Patients With Complement-Mediated Kidney Disease

IgA Nephropathy

New Zealand
CSL Limited

Completed

Subcutaneous Ig NextGen 16% in PID Patients

Primary Immunodeficiency (PID)

Australia, New Zealand
Malaghan Institute of Medical Research
Wellington Zhaotai Therapies Limited (WZTL)

Recruiting

ENABLE (Engaging Toll-like Receptor Signalling for B-cell Lymphoma Chimeric Antigen Receptor Therapy) (ENABLE)

Mantle Cell Lymphoma (MCL) | Diffuse Large B-cell Lymphoma (DLBCL) | Follicular Lymphoma (FL) | Lymphomas Non-Hodgkin's B-Cell | Transformed Follicular Lymphoma (TFL) | Primary Mediastinal B-cell Lymphoma (PMBCL)

New Zealand
Auckland District Health Board
Novartis; University of Auckland, New Zealand; IGENZ, Ltd., Auckland

Unknown

1st-line Activity of Dovitinib and Correlation With Genetic Changes in RCC (DILIGENCE-1)

Clear Cell Renal Cell Carcinoma

New Zealand

Clinical Trials on Primary Sjögren Syndrome in New Zealand

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Norway

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations